Article
Site specific screening for point mutations in ornithine transcarbamylase deficiency.
Journal of medical genetics - 1 Jul 1992
Feldmann D, Rozet J M, Pelet A, Hentzen D, Briand P, Hubert P, Largilliere C, Rabier D, Farriaux J P, Munnich A
Abstract excerpt
Ornithine transcarbamylase (OTC) deficiency is a frequent X linked disorder of the urea cycle which is responsible for lethal neonatal hyperammonaemia in males and for various clinical symptoms in heterozygous females. In order to improve the efficiency of our screening for mutant genotypes, we focused on molecular domains of functional or structural importance in the OTC gene, namely the carbamyl phosphate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
